Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 63,543 | 64,223 | 68,033 | 59,366 | 76,912 |
| Cost of Goods | 43,575 | 36,611 | 36,319 | 34,464 | 43,741 |
| Gross Profit | 19,968 | 27,612 | 31,714 | 24,902 | 33,171 |
| Operating Expenses | 25,369 | 22,426 | 21,703 | 21,291 | 19,541 |
| Operating Income | -4,826 | 5,797 | 10,330 | 4,075 | 14,371 |
| Interest Expense | 54 | 281 | 305 | 384 | 204 |
| Other Income | -59 | 485 | -273 | 125 | -3,829 |
| Pre-tax Income | -4,939 | 6,001 | 9,752 | 3,816 | 10,338 |
| Income Tax | -1,485 | 2,111 | 2,857 | 1,327 | 2,805 |
| Net Income Continuous | -3,454 | 3,890 | 6,895 | 2,489 | 7,533 |
| Net Income | $-3,454 | $3,890 | $6,895 | $2,489 | $7,533 |
| EPS Basic Total Ops | -0.08 | 0.09 | 0.15 | 0.06 | 0.17 |
| EPS Basic Continuous Ops | -0.08 | 0.09 | 0.15 | 0.06 | 0.17 |
| EPS Diluted Total Ops | -0.07 | 0.08 | 0.15 | 0.05 | 0.17 |
| EPS Diluted Continuous Ops | -0.08 | 0.08 | 0.15 | 0.05 | 0.17 |
| EBITDA(a) | $-908 | $9,512 | $13,947 | $7,503 | $17,649 |